Trial intelligence / Profile preview

Single-dose pharmacokinetics study of micafungin sodium in healthy Chinese volunteers

ChiCTR-ONRC-10000763Phase 4Completed

Sponsor
Chinese PLA General Hospital
Start
Dec 2009
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of micafungin in fungemia, aspergillosis and candidiasis (3 arms), sponsored by Chinese PLA General Hospital. Primary endpoint: Micafungin sodium plasma concentration. Started Dec 2009; status: completed.

02

Drugs

micafungin
03

Conditions

fungemiaaspergillosiscandidiasis

Beyond the preview

Go deeper on ChiCTR-ONRC-10000763.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-ONRC-10000763.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call